The kinase inhibitor LS104 induces apoptosis, enhances cytotoxic effects of chemotherapeutic drugs and is targeting the receptor tyrosine kinase FLT3 in acute myeloid leukemia (Q46538314)
scientific article published on 16 June 2008
Language:
Current Data About The kinase inhibitor LS104 induces apoptosis, enhances cytotoxic effects of chemotherapeutic drugs and is targeting the receptor tyrosine kinase FLT3 in acute myeloid leukemia
(P31) (Q13442814)
(P248)
(P698) 18556063
(P813) Saturday, December 23, 2017
(P854) http://europepmc.org/abstract/MED/18556063

(P50) (Q95028765)
(P1545) 7
(P1932) Christoph Huber
(P248)
(P698) 18556063
(P813) Saturday, December 23, 2017
(P854) http://europepmc.org/abstract/MED/18556063

(P304) 1698-1708
(P248)
(P698) 18556063
(P813) Saturday, December 23, 2017
(P854) http://europepmc.org/abstract/MED/18556063

(P433) 11
(P248)
(P698) 18556063
(P813) Saturday, December 23, 2017
(P854) http://europepmc.org/abstract/MED/18556063

(P478) 32
(P248)
(P698) 18556063
(P813) Saturday, December 23, 2017
(P854) http://europepmc.org/abstract/MED/18556063

(P577) Monday, June 16, 2008
(P248)
(P698) 18556063
(P813) Saturday, December 23, 2017
(P854) http://europepmc.org/abstract/MED/18556063

(P921) (Q246181)

(Q974135)
(P887)

(P1433) (Q15716445)
(P248)
(P698) 18556063
(P813) Saturday, December 23, 2017
(P854) http://europepmc.org/abstract/MED/18556063

(P1476) "The kinase inhibitor LS104 induces apoptosis, enhances cytotoxic effects of chemotherapeutic drugs and is targeting the receptor tyrosine kinase FLT3 in acute myeloid leukemia" (language: en)
(P248)
(P698) 18556063
(P813) Saturday, December 23, 2017
(P854) http://europepmc.org/abstract/MED/18556063

(P2093) Stefan Kasper
(P1545) 1
(P248)
(P698) 18556063
(P813) Saturday, December 23, 2017
(P854) http://europepmc.org/abstract/MED/18556063

Frank Breitenbuecher
(P1545) 2
(P248)
(P698) 18556063
(P813) Saturday, December 23, 2017
(P854) http://europepmc.org/abstract/MED/18556063

Yvette Hoehn
(P1545) 3
(P248)
(P698) 18556063
(P813) Saturday, December 23, 2017
(P854) http://europepmc.org/abstract/MED/18556063

Florian Heidel
(P1545) 4
(P248)
(P698) 18556063
(P813) Saturday, December 23, 2017
(P854) http://europepmc.org/abstract/MED/18556063

Daniel B Lipka
(P1545) 5
(P248)
(P698) 18556063
(P813) Saturday, December 23, 2017
(P854) http://europepmc.org/abstract/MED/18556063

Boyka Markova
(P1545) 6
(P248)
(P698) 18556063
(P813) Saturday, December 23, 2017
(P854) http://europepmc.org/abstract/MED/18556063

Thomas Kindler
(P1545) 8
(P248)
(P698) 18556063
(P813) Saturday, December 23, 2017
(P854) http://europepmc.org/abstract/MED/18556063

Thomas Fischer
(P1545) 9
(P248)
(P698) 18556063
(P813) Saturday, December 23, 2017
(P854) http://europepmc.org/abstract/MED/18556063

other details
description scientific article published on 16 June 2008

External Links
(P356) 10.1016/J.LEUKRES.2008.05.003
(P698) 18556063
(P5875) 5300843